Plain-English translation of NCT04903951 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether a device called DreamStation BiPAP autoSV can help people recover better after their first stroke if they also have sleep apnea. The device provides gentle breathing support while you sleep or rest during the day. Half of the participants will receive this treatment along with standard stroke care, while the other half will receive standard care alone.
Sleep apnea is very common after a stroke and can make recovery harder by reducing oxygen to the brain during sleep. Researchers want to know whether starting breathing support therapy early — within days of the stroke — might improve how well people recover and prevent future strokes.
You likely qualify if…
You likely don't qualify if…
You will be randomly placed into one of two groups. If you are in the treatment group, you will use the breathing support device during sleep and rest periods each day from the time you start until it is no longer medically necessary. All participants will receive standard stroke rehabilitation and medical care. The study includes baseline testing, regular follow-up visits while you recover, and a follow-up phone call to check on your progress.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Portugal
Phase
Testing effectiveness
Sponsor
Philips Portuguesa S.A.
Enrollment target
~90 participants
Started
February 2024
Primary completion
August 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sílvia Correia, MD
Trofa Saúde Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.